Efficacy of Alpha-Blocker Add-on Therapy to Tadarafil Treated Men with Lower Urinary Tract Sympto
Not Applicable
- Conditions
- benign prostatic hypertrophy
- Registration Number
- JPRN-UMIN000015311
- Lead Sponsor
- Department of Urology, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 58
Inclusion Criteria
Not provided
Exclusion Criteria
1. Prostate cancer 2. Episode of urinary retention within 6 months 3. Residual urine volume >150ml 4. Urinary tract infection, neurogenic bladder
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method OABSS, IPSS and urodynamic parameter such as Qmax and residual volue of urine.
- Secondary Outcome Measures
Name Time Method